Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer 2019
2019 O-GlcNAcylation of GLI transcription factors in hyperglycemic conditions augments Hedgehog activity 2019
2019 The nucleolus: a central response hub for the stressors that drive cancer progression 2019
2018 Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer [Oncotarget., 7, (2016) (86803-86815)] 10.18632/oncotarget.13466 2018
2018 Conditional knockout of N-Myc and STAT interactor disrupts normal mammary development and enhances metastatic ability of mammary tumors 2018
2018 Evaluating the use of external beam radiation alone in the management of cervix cancer 2018
2018 Deficiency of tumor suppressor Merlin facilitates metabolic adaptation by co-operative engagement of SMAD-Hippo signaling in breast cancer 2018
2018 Phage ligands for identification of mesenchymal-like breast cancer cells and cancer-associated fibroblasts 2018
2017 Methods to Evaluate Cell Growth, Viability, and Response to Treatment in a Tissue Engineered Breast Cancer Model 2017
2017 Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival 2017
2017 Developing Cures: Targeting Ontogenesis in Cancer 2017
2017 Loss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signaling 2017
2016 Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer 2016
2016 Roles of N-Myc and STAT interactor in cancer: From initiation to dissemination 2016
2016 Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer 2016
2016 Niclosamide and its analogs are potent inhibitors of Wnt/ß- catenin, mTOR and STAT3 signaling in ovarian cancer 2016
2015 Nuclear Localization of DNAJB6 Is Associated with Survival of Patients with Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells 2015
2015 The impact of hedgehog signaling pathway on DNA repair mechanisms in human cancer 2015
2015 N-Myc and STAT Interactor regulates autophagy and chemosensitivity in breast cancer cells 2015
2014 MicroRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer 2014
2014 Multi-targeted therapy of cancer by niclosamide: A new application for an old drug 2014
2014 Nonclassical HEDGEHOG-GLI signaling and its clinical implications 2014
2014 Role of osteopontin in the pathophysiology of cancer 2014
2014 Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signaling 2014
2014 Effect of niclosamide on basal-like breast cancers 2014
2014 Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer 2014
2014 NMI and EMT 2014
2013 Nonclassical activation of Hedgehog signaling enhances multidrug resistance and makes cancer cells refractory to smoothened-targeting Hedgehog inhibition 2013
2012 Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs 2012
2012 DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3β to downregulate β-catenin transcription target, osteopontin 2012
2012 Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance: NUPR1 and p21 in chemoresistance 2012
2012 Micro-RNA-632 downregulates DNAJB6 in breast cancer 2012
2012 Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61 2012
2012 DNAJB6 governs a novel regulatory loop determining Wnt/β-catenin signalling activity 2012
2012 Cellular stress stimulates nuclear localization signal (NLS) independent nuclear transport of MRJ 2012
2012 Dickkopf1: A tumor suppressor or metastasis promoter? 2012
2012 Hedgehog signaling in tumor cells facilitates osteoblast-enhanced osteolytic metastases 2012
2012 Location, location, location: The BRMS1 protein and melanoma progression 2012
2012 Location, location, location: The BRMS1 protein and melanoma progression 2012
2012 The hedgehog pathway conditions the bone microenvironment for osteolytic metastasis of breast cancer. 2012
2012 The influence of the cancer microenvironment on the process of metastasis. 2012
2011 Loss of tumor suppressor merlin in advanced breast cancer is due to post-translational regulation 2011
2011 Hedgehog signaling: Networking to nurture a promalignant tumor microenvironment 2011
2011 Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis 2011
2011 Recent advances in anti-angiogenic therapy of cancer 2011
2010 DNAJB6 induces degradation of β-catenin and causes partial reversal of mesenchymal phenotype 2010
2010 Functional characterization of the progestagen-associated endometrial protein gene in human melanoma 2010
2010 Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontin 2010
2010 Osteopontin: An effector and an effect of tumor metastasis 2010
2010 Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1 2010
2009 Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma 2009
2009 The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin 2009
2009 Multi-faceted role of HSP40 in cancer 2009
2009 Nmi (N-Myc interactor) inhibits Wnt/β-catenin signaling and retards tumor growth 2009
2009 Emerging role of nuclear protein 1 (NUPR1) in cancer biology 2009
2008 Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer 2008
2008 NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress 2008
2008 The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. 2008
2008 Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer 2008
2008 Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells 2008
2008 Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer 2008
2008 BRMS1 2008
2008 Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts 2008
2007 Rac1 activity regulates proliferation of aggressive metastatic melanoma 2007
2007 Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-κB activation 2007
2006 Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone 2006
2006 Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1) 2006
2006 Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435 2006
2005 Radiotherapy basics for family physicians. Potent tool for symptom relief 2005
2005 Radiotherapy for the treatment of primary vaginal cancer 2005
2005 Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells 2005
2004 Breast cancer metastatic potential: Correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells 2004
2004 A small molecule antagonist of the αυβ 3 integrin suppresses MDA-MB-435 skeletal metastasis 2004
2004 Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells 2004
2004 Breast Cancer Metastasis Suppressor 1 (BRMS1) Forms Complexes with Retinoblastoma-binding Protein 1 (RBP1) and the mSin3 Histone Deacetylase Complex and Represses Transcription 2004
2004 Inhibition of prostate cancer metastatic colonization by ∼4.2 Mb of human chromosome 12 2004
2002 Comparative sequence analysis in eight inbred strains of the metastasis modifier QTL candidate gene Brms1 2002
2002 Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells 2002
2002 Identification and characterization of the murine ortholog (brms1) of breast-cancer metastasis suppressor 1 (BRMS1). 2002
2002 Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1 2002
2001 Analysis of mechanisms underlying BRMS1 suppression of metastasis 2001
2001 Metastasis suppression in prostate cancer 2001
2000 Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13 2000

Full Name

  • Rajeev Samant